Exact Mass: 344.2464

Exact Mass Matches: 344.2464

Found 100 metabolites which its exact mass value is equals to given mass value 344.2464, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

16b-Hydroxystanozolol

(1S,2S,10S,13R,14S,16S,17R,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icosa-4(8),5-diene-16,17-diol

C21H32N2O2 (344.2464)


16b-Hydroxystanozolol is the major metabolite of stanozolol. Stanozolol is an anabolic steroid illicitly used for growth promoting purposes in animal production. For reasons of public health the use of anabolic steroids as growth promoters is officially banned in Europe in animals intended for consumption. Stanozolol is an anabolic steroid banned in competing athletes. Doping control screening for the analysis of anabolic steroids in human urine or the detection of anabolic steroid residues in cattles urine is achieved using liquid and gas chromatography time-of-flight mass spectrometry, liquid chromatography-tandem mass spectrometry or through a combination of liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry. Androgenic anabolic steroids are defined as natural, synthetic or semi-synthetic drugs chemicals derived from testosterone, used with the aim to improve physical performance by increasing both muscle strength and mass. Despite their reported toxicological effects on the cardiovascular, hepatic and neuro-endocrine systems, the AAS have been extensively used in sports activities. (PMID: 15782394, 17610244, 17724580) [HMDB] 16b-Hydroxystanozolol is the major metabolite of stanozolol. Stanozolol is an anabolic steroid illicitly used for growth promoting purposes in animal production. For reasons of public health the use of anabolic steroids as growth promoters is officially banned in Europe in animals intended for consumption. Stanozolol is an anabolic steroid banned in competing athletes. Doping control screening for the analysis of anabolic steroids in human urine or the detection of anabolic steroid residues in cattles urine is achieved using liquid and gas chromatography time-of-flight mass spectrometry, liquid chromatography-tandem mass spectrometry or through a combination of liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry. Androgenic anabolic steroids are defined as natural, synthetic or semi-synthetic drugs chemicals derived from testosterone, used with the aim to improve physical performance by increasing both muscle strength and mass. Despite their reported toxicological effects on the cardiovascular, hepatic and neuro-endocrine systems, the AAS have been extensively used in sports activities. (PMID: 15782394, 17610244, 17724580).

   

3'-Hydroxystanozolol

(1S,2S,10S,13R,14S,17S,18S)-17-hydroxy-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icos-4(8)-en-5-one

C21H32N2O2 (344.2464)


3-Hydroxystanozolol is a metabolite of stanozolol. Stanozolol has the potential for misuse as an anabolic steroid in horse racing. Stanozolol is an anabolic steroid illicitly used for growth promoting purposes in animal production. For reasons of public health the use of anabolic steroids as growth promoters is officially banned in Europe in animals intended for consumption. Stanozolol is a synthetic anabolic androgenic steroid often abused in sports to enhance performance. Doping control screening for the analysis of anabolic steroids in human urine or the detection of anabolic steroid residues in cattles urine is achieved using liquid and gas chromatography time-of-flight mass spectrometry, liquid chromatography-tandem mass spectrometry or through a combination of liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry. Androgenic anabolic steroids are defined as natural, synthetic or semi-synthetic drugs chemicals derived from testosterone, used with the aim to improve physical performance by increasing both muscle strength and mass. Despite their reported toxicological effects on the cardiovascular, hepatic and neuro-endocrine systems, the AAS have been extensively used in sports activities. [HMDB] 3-Hydroxystanozolol is a metabolite of stanozolol. Stanozolol has the potential for misuse as an anabolic steroid in horse racing. Stanozolol is an anabolic steroid illicitly used for growth promoting purposes in animal production. For reasons of public health the use of anabolic steroids as growth promoters is officially banned in Europe in animals intended for consumption. Stanozolol is a synthetic anabolic androgenic steroid often abused in sports to enhance performance. Doping control screening for the analysis of anabolic steroids in human urine or the detection of anabolic steroid residues in cattles urine is achieved using liquid and gas chromatography time-of-flight mass spectrometry, liquid chromatography-tandem mass spectrometry or through a combination of liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry. Androgenic anabolic steroids are defined as natural, synthetic or semi-synthetic drugs chemicals derived from testosterone, used with the aim to improve physical performance by increasing both muscle strength and mass. Despite their reported toxicological effects on the cardiovascular, hepatic and neuro-endocrine systems, the AAS have been extensively used in sports activities.

   

DG(8:0/8:0/0:0)

Octanoic acid, 1-(hydroxymethyl)-1,2-ethanediyl ester

C19H36O5 (344.2563)


Diglycerides (DGs) are also known as diacylglycerols or diacylglycerides, meaning that they are glycerides consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. DG(8:0/8:0/0:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of caprylic acid at the C-2 position. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Diacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. C78276 - Agent Affecting Digestive System or Metabolism

   

4b-Hydroxystanozolol

(1S,2R,9R,10R,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icosa-4(8),5-diene-9,17-diol

C21H32N2O2 (344.2464)


4b-Hydroxystanozolol is a metabolite of stanozolol. Stanozolol has the potential for misuse as an anabolic steroid in horse racing. Stanozolol is an anabolic steroid illicitly used for growth promoting purposes in animal production. For reasons of public health the use of anabolic steroids as growth promoters is officially banned in Europe in animals intended for consumption. Stanozolol is a synthetic anabolic androgenic steroid often abused in sports to enhance performance. Doping control screening for the analysis of anabolic steroids in human urine or the detection of anabolic steroid residues in cattles urine is achieved using liquid and gas chromatography time-of-flight mass spectrometry, liquid chromatography-tandem mass spectrometry or through a combination of liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry. (PMID: 16040239, 17724580, 17610244, 15782394).

   

DG(8:0/0:0/8:0)

2-hydroxy-3-(octanoyloxy)propyl octanoate

C19H36O5 (344.2563)


DG(8:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

1,2-Dioctanoylglycerol

1-hydroxy-3-(octanoyloxy)propan-2-yl octanoate

C19H36O5 (344.2563)


C78276 - Agent Affecting Digestive System or Metabolism

   

1-O-Myristoyl-2-acetyl-glycerol

2-(acetyloxy)-3-hydroxypropyl tetradecanoate

C19H36O5 (344.2563)


   

Bempedoic acid

8-Hydroxy-2,2,14,14-tetramethylpentadecanedioic acid

C19H36O5 (344.2563)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C80482 - Non-Statin Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites D007004 - Hypoglycemic Agents D004791 - Enzyme Inhibitors Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor[1]. Bempedoic acid (ETC-1002) activates AMPK[2].

   

18,19-Dinorcholesta-1,3,5,7,9,11,13-heptaene,17-methyl-, (17a)- (9CI)

18,19-Dinorcholesta-1,3,5,7,9,11,13-heptaene,17-methyl-, (17a)- (9CI)

C26H32 (344.2504)


   

methyl 11,12,15-trihydroxy-13(14)-octadecenoate

methyl 11,12,15-trihydroxy-13(14)-octadecenoate

C19H36O5 (344.2563)


   

lannotinidine H

lannotinidine H

C21H32N2O2 (344.2464)


   

(9E)-8,11,12-trihydroxyoctadecenoic acid methyl ester|tianshic acid methyl ester

(9E)-8,11,12-trihydroxyoctadecenoic acid methyl ester|tianshic acid methyl ester

C19H36O5 (344.2563)


   

SCHEMBL6507566

SCHEMBL6507566

C19H36O5 (344.2563)


   

METHYL 9,12,13-TRIHYDROXYOCTADEC-10-ENOATE

METHYL 9,12,13-TRIHYDROXYOCTADEC-10-ENOATE

C19H36O5 (344.2563)


   

methyl 9,10,13-trihydroxy-11-octadecenoate

methyl 9,10,13-trihydroxy-11-octadecenoate

C19H36O5 (344.2563)


   

9-hydroxynonadecane-1,19-dioic acid

9-hydroxynonadecane-1,19-dioic acid

C19H36O5 (344.2563)


   
   
   
   
   
   

valylvalyllysine

valylvalyllysine

C16H32N4O4 (344.2423)


   
   

3-Hydroxystanozolol

3-Hydroxystanozolol

C21H32N2O2 (344.2464)


   

stanozolol-4b-OH

stanozolol-4b-OH

C21H32N2O2 (344.2464)


   

stanozolol-16-OH

stanozolol-16-OH

C21H32N2O2 (344.2464)


   

stanozolol-3-OH

stanozolol-3-OH

C21H32N2O2 (344.2464)


   

h_88_stanozolol_4b_oh

h_88_stanozolol_4b_oh

C21H32N2O2 (344.2464)


   

h_13_stanozolol_3OH

h_13_stanozolol_3OH

C21H32N2O2 (344.2464)


   

h_36_stanozolol_4bOH

h_36_stanozolol_4bOH

C21H32N2O2 (344.2464)


   
   
   

4β-Hydroxystanozolol

4β-Hydroxystanozolol

C21H32N2O2 (344.2464)


   

16β-Hydroxystanozolol

16β-Hydroxystanozolol

C21H32N2O2 (344.2464)


   

16α-Hydroxystanozolol

16α-Hydroxystanozolol

C21H32N2O2 (344.2464)


   

3-Hydroxy-17-epistanozolol

3-Hydroxy-17-epistanozolol

C21H32N2O2 (344.2464)


   

16α-Hydroxy-17-epistanozolol

16α-Hydroxy-17-epistanozolol

C21H32N2O2 (344.2464)


   

UNII:SA9937IP23

1,2-bis(O-octanoyl)-sn-glycerol

C19H36O5 (344.2563)


1,2-diacyl-sn-glycerol in which both the 1- and 2-acyl groups are specified as octanoyl. Formula C19H36O5.

   

12,13-dihydroxy-11-methoxy-9-octadecenoic acid

12,13-dihydroxy-11-methoxy-9-octadecenoic acid

C19H36O5 (344.2563)


   

FA 19:1;O3

12,13-dihydroxy-11-methoxy-9-octadecenoic acid

C19H36O5 (344.2563)


   

FOH 19:2;O4

(9S,10S,11R)-trihydroxy-12Z-octadecenoic aci

C19H36O5 (344.2563)


   

Siegesbeckin A

3R-dodecanoyloxy-2R-hydroxy-4-methylpentanoic acid methyl ester

C19H36O5 (344.2563)


   

Siegesbeckin B

2R-dodecanoyloxy-3R-hydroxy-4-methylpentanoic acid methyl ester

C19H36O5 (344.2563)


   

tert-butyl 9-benzyl-2,9-diazaspiro[5.5]undecane-2-carboxylate

tert-butyl 9-benzyl-2,9-diazaspiro[5.5]undecane-2-carboxylate

C21H32N2O2 (344.2464)


   

Tert-Butyl 9-benzyl-3,9-diazaspiro[5.5]undecane-3-carboxylate

Tert-Butyl 9-benzyl-3,9-diazaspiro[5.5]undecane-3-carboxylate

C21H32N2O2 (344.2464)


   

boc-homoarg(et)2-oh

boc-homoarg(et)2-oh

C16H32N4O4 (344.2423)


   

Boc-D-Homoarg(Et)2-OH

Boc-D-Homoarg(Et)2-OH

C16H32N4O4 (344.2423)


   

Poly(titanium butoxide)

Poly(titanium butoxide)

C16H40O4Ti (344.2406)


   

1,2-dioctanoyl-sn-glycerol

1,2-dioctanoyl-sn-glycerol

C19H36O5 (344.2563)


   

Dihydroxyaluminium stearate

Dihydroxyaluminium stearate

C18H37AlO4 (344.2507)


   

tert-butyl 8-benzyl-2,8-diazaspiro[4.5]decane-2-carboxylate

tert-butyl 8-benzyl-2,8-diazaspiro[4.5]decane-2-carboxylate

C21H32N2O2 (344.2464)


   

(5alpha,17beta)-Spiro[androstane-3,3-[3H]diazirin]-17-ol 17-acetate

(5alpha,17beta)-Spiro[androstane-3,3-[3H]diazirin]-17-ol 17-acetate

C21H32N2O2 (344.2464)


   

9,12-Octadecadien-1-ol, methanesulfonate, (9Z,12Z)-

9,12-Octadecadien-1-ol, methanesulfonate, (9Z,12Z)-

C19H36O3S (344.2385)


   

Poly(titanium(IV) n-butoxide)

Poly(titanium(IV) n-butoxide)

C16H40O4Ti (344.2406)


   

1,9-Diazaspiro[5.5]undecane-9-carboxylic acid, 1-(phenylmethyl)-, 1,1-dimethylethyl ester

1,9-Diazaspiro[5.5]undecane-9-carboxylic acid, 1-(phenylmethyl)-, 1,1-dimethylethyl ester

C21H32N2O2 (344.2464)


   

2,9-Diazaspiro[5.5]undecane-9-carboxylic acid, 2-(phenylmethyl)-, 1,1-dimethylethyl ester

2,9-Diazaspiro[5.5]undecane-9-carboxylic acid, 2-(phenylmethyl)-, 1,1-dimethylethyl ester

C21H32N2O2 (344.2464)


   

1,3-Dioctanoylglycerol

1,3-Dioctanoylglycerol

C19H36O5 (344.2563)


A 1,3-diglyceride in which both acyl groups are specified as octanoyl.

   

4beta-Hydroxystanozolol

4beta-Hydroxystanozolol

C21H32N2O2 (344.2464)


   

2,3-Dioctanoylglycerol

2,3-Dioctanoylglycerol

C19H36O5 (344.2563)


   

L-Lysine, L-valyl-L-valyl-

L-Lysine, L-valyl-L-valyl-

C16H32N4O4 (344.2423)


   

Bempedoic acid

Bempedoic acid

C19H36O5 (344.2563)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C80482 - Non-Statin Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites D007004 - Hypoglycemic Agents D004791 - Enzyme Inhibitors Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor[1]. Bempedoic acid (ETC-1002) activates AMPK[2].

   

di(2-propylC5)

di(2-propylC5)

C19H36O5 (344.2563)


   

[3-carboxy-2-[(E)-2-hydroxyundec-3-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-2-hydroxyundec-3-enoyl]oxypropyl]-trimethylazanium

C18H34NO5+ (344.2437)


   

[3-carboxy-2-[(E)-2-hydroxyundec-8-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-2-hydroxyundec-8-enoyl]oxypropyl]-trimethylazanium

C18H34NO5+ (344.2437)


   

[3-carboxy-2-[(E)-2-hydroxyundec-6-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-2-hydroxyundec-6-enoyl]oxypropyl]-trimethylazanium

C18H34NO5+ (344.2437)


   

[3-carboxy-2-[(E)-2-hydroxyundec-5-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-2-hydroxyundec-5-enoyl]oxypropyl]-trimethylazanium

C18H34NO5+ (344.2437)


   

[3-carboxy-2-[(E)-2-hydroxyundec-4-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-2-hydroxyundec-4-enoyl]oxypropyl]-trimethylazanium

C18H34NO5+ (344.2437)


   

[3-carboxy-2-[(E)-2-hydroxyundec-7-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-2-hydroxyundec-7-enoyl]oxypropyl]-trimethylazanium

C18H34NO5+ (344.2437)


   

[3-carboxy-2-[(Z)-2-hydroxyundec-2-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(Z)-2-hydroxyundec-2-enoyl]oxypropyl]-trimethylazanium

C18H34NO5+ (344.2437)


   

[3-carboxy-2-[(E)-2-hydroxyundec-9-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-2-hydroxyundec-9-enoyl]oxypropyl]-trimethylazanium

C18H34NO5+ (344.2437)


   

[3-Carboxy-2-(3-oxoundecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(3-oxoundecanoyloxy)propyl]-trimethylazanium

C18H34NO5+ (344.2437)


   

Tianshic acid methyl ester

Tianshic acid methyl ester

C19H36O5 (344.2563)


A fatty acid methyl ester of tianshic acid. It has been isolated from the stems of Sambucus williamsii.

   

1-[(6,6-dimethyl-4-bicyclo[3.1.1]hept-3-enyl)methoxy]-3-(1-methyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazin-2-yl)-2-propanol

1-[(6,6-dimethyl-4-bicyclo[3.1.1]hept-3-enyl)methoxy]-3-(1-methyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazin-2-yl)-2-propanol

C21H32N2O2 (344.2464)


   

2-(dimethylamino)-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[[oxo-(propan-2-ylamino)methyl]amino]ethyl]-3-oxanyl]acetamide

2-(dimethylamino)-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[[oxo-(propan-2-ylamino)methyl]amino]ethyl]-3-oxanyl]acetamide

C16H32N4O4 (344.2423)


   
   
   

(1-Hexanoyloxy-3-hydroxypropan-2-yl) decanoate

(1-Hexanoyloxy-3-hydroxypropan-2-yl) decanoate

C19H36O5 (344.2563)


   

(1-Hydroxy-3-propanoyloxypropan-2-yl) tridecanoate

(1-Hydroxy-3-propanoyloxypropan-2-yl) tridecanoate

C19H36O5 (344.2563)


   

(1-Acetyloxy-3-hydroxypropan-2-yl) tetradecanoate

(1-Acetyloxy-3-hydroxypropan-2-yl) tetradecanoate

C19H36O5 (344.2563)


   

(1-Heptanoyloxy-3-hydroxypropan-2-yl) nonanoate

(1-Heptanoyloxy-3-hydroxypropan-2-yl) nonanoate

C19H36O5 (344.2563)


   

(1-Butanoyloxy-3-hydroxypropan-2-yl) dodecanoate

(1-Butanoyloxy-3-hydroxypropan-2-yl) dodecanoate

C19H36O5 (344.2563)


   

(1-Hydroxy-3-pentanoyloxypropan-2-yl) undecanoate

(1-Hydroxy-3-pentanoyloxypropan-2-yl) undecanoate

C19H36O5 (344.2563)


   

16beta-Hydroxystanozolol

16beta-Hydroxystanozolol

C21H32N2O2 (344.2464)


   

9,10,11-trihydroxy-12Z-octadecenoic acid

9,10,11-trihydroxy-12Z-octadecenoic acid

C19H36O5 (344.2563)


   

dioctanoylglycerol

dioctanoylglycerol

C19H36O5 (344.2563)


A diglyceride obtained by acylation of any two hydroxy groups of glycerol by octanoic acid. Formula C19H36O5. For the structure shown, either R1 = H and R2 = octanoyl or R1 = octanoyl and R2 = H.

   

2,3-dioctanoyl-sn-glycerol

2,3-dioctanoyl-sn-glycerol

C19H36O5 (344.2563)


A 2,3-diacyl-sn-glycerol in which both the 2- and 3-acyl groups are specified as octanoyl.

   

Dihydroxymethoxyoctadecenoic acid

Dihydroxymethoxyoctadecenoic acid

C19H36O5 (344.2563)


   
   
   
   

Hydroxystanozolol

Hydroxystanozolol

C21H32N2O2 (344.2464)


   

n-[(1s,2r,7r,13r,15s)-15-methyl-7-(2-oxopropyl)-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-10-en-11-yl]ethanimidic acid

n-[(1s,2r,7r,13r,15s)-15-methyl-7-(2-oxopropyl)-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-10-en-11-yl]ethanimidic acid

C21H32N2O2 (344.2464)


   

(9r)-9-hydroxynonadecanedioic acid

(9r)-9-hydroxynonadecanedioic acid

C19H36O5 (344.2563)


   

methyl (8r,9e,11s,12s)-8,11,12-trihydroxyoctadec-9-enoate

methyl (8r,9e,11s,12s)-8,11,12-trihydroxyoctadec-9-enoate

C19H36O5 (344.2563)


   

n-[15-methyl-7-(2-oxopropyl)-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-10-en-11-yl]ethanimidic acid

n-[15-methyl-7-(2-oxopropyl)-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-10-en-11-yl]ethanimidic acid

C21H32N2O2 (344.2464)


   

n-[(1r,2r,7r,13s,15r)-15-methyl-7-(2-oxopropyl)-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-10-en-11-yl]ethanimidic acid

n-[(1r,2r,7r,13s,15r)-15-methyl-7-(2-oxopropyl)-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-10-en-11-yl]ethanimidic acid

C21H32N2O2 (344.2464)


   

2,3-dihydroxy-2-(1-hydroxytridecyl)-4-methoxycyclopentan-1-one

2,3-dihydroxy-2-(1-hydroxytridecyl)-4-methoxycyclopentan-1-one

C19H36O5 (344.2563)


   

methyl 8,11,12-trihydroxyoctadec-9-enoate

methyl 8,11,12-trihydroxyoctadec-9-enoate

C19H36O5 (344.2563)


   

(2s,3r)-2,3-dihydroxy-2-(1-hydroxytridecyl)-4-methoxycyclopentan-1-one

(2s,3r)-2,3-dihydroxy-2-(1-hydroxytridecyl)-4-methoxycyclopentan-1-one

C19H36O5 (344.2563)


   

9-hydroxynonadecanedioic acid

9-hydroxynonadecanedioic acid

C19H36O5 (344.2563)